Wegovy Cost UK

Summary: On the NHS in England Wegovy costs £9.90 per prescription, free elsewhere in the UK, but eligibility runs through specialist weight management services with long waits. Privately it runs around £130 to £300 per month, priced dose by dose.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: Wegovy costs £9.90 per item on an NHS prescription in England, and is free at the point of dispensing in Scotland, Wales, and Northern Ireland. If you do not qualify for the NHS route, a private prescription runs roughly £130 to £300 per month depending on the dose and the pharmacy. The list price Novo Nordisk publishes to NICE for the highest dose is £175.80 per pen pack. Private pharmacies mark up from there, and they price each of the six dose strengths separately, so your monthly cost climbs as you titrate.

Below is the full breakdown: who actually gets Wegovy on the NHS, what each dose costs at the major UK pharmacies, why the same drug ranges by more than £100 a month across providers, and how that compares to private Mounjaro pricing right now.

NHS Wegovy: the prescription charge is the small part

The headline figure is £9.90 per prescription item in England, or free in Scotland, Wales, and Northern Ireland. For long courses, a 12-month prescription prepayment certificate in England caps the total at £114.50 regardless of how many items you collect [3]. That part of the cost is trivial.

The reason most people who want Wegovy do not get it on the NHS is the access pathway, not the dispensing fee.

NICE technology appraisal TA875, published March 2023, recommends semaglutide 2.4 mg for adults with [1]:

  • BMI of at least 35 kg/m², or
  • BMI of 30 to 34.9 kg/m² with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease).

Thresholds are reduced by 2.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family backgrounds, reflecting earlier metabolic risk at lower BMI. You also need documented evidence of structured lifestyle intervention before the prescription is written.

Two access constraints sit on top of those clinical thresholds and they matter more in practice:

  1. Wegovy can only be initiated by a specialist weight management service, called Tier 3 in most NHS regions. A GP cannot start it. GPs can write repeats after specialist initiation in some ICBs, but only after handover from the clinic [3].
  2. NICE originally restricted treatment duration to a maximum of 2 years. NHS England has since clarified through commissioning guidance that ICBs can support continuation past two years where clinical benefit is sustained, but the default is still a two-year course, and most integrated care boards interpret the cap strictly [1][3].

Waiting lists for Tier 3 services run 12 to 24 months in most regions of England, and several ICBs paused new Wegovy referrals during the 2023 to 2024 Novo Nordisk supply shortage. BBC reporting on the rollout flagged that fewer than 50,000 NHS patients were on the drug a year after launch, against an eligible population estimated in the hundreds of thousands [5].

Private Wegovy: what £130 to £300 a month actually buys

If you do not qualify for NHS access, or you do not want to wait two years for a slot, the only legal alternative in the UK is a private prescription dispensed through a GPhC-registered pharmacy. Wegovy is a prescription-only medicine and Novo Nordisk does not sell it direct to consumers. Every private order goes through a licensed prescriber and a registered pharmacy.

Two facts shape the price you see:

  • The NICE-listed UK price for Wegovy is £175.80 per pack of four pens at the maintenance dose (2.4 mg). Lower doses are listed at £73.25 (0.25 mg, 0.5 mg, 1.0 mg) and £124.53 (1.7 mg) per pack of four pens. These are list prices, not retail.
  • Private pharmacies add their own margin on top, plus a clinical fee for the prescriber consultation, plus delivery in a temperature-controlled box. That is where the £130 to £300 monthly spread comes from.

Dose-by-dose pricing across major UK pharmacies

Wegovy titrates over 16 to 20 weeks across six dose strengths: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg, and 7.2 mg. The 7.2 mg pen was approved more recently as a higher maintenance option. Each strength is dispensed as a pack of four FlexTouch pens for a month of weekly injections. Private pharmacies price each strength separately, so your monthly bill increases as you climb the ladder.

The table below summarises standard retail prices (before discount codes) from a sample of large UK online pharmacies. Prices were tracked in May 2026 and change frequently.

Pharmacy0.25 mg1.0 mg2.4 mg7.2 mg
Asda£92£142£192£252
Lloyds£106£156£206£296
Pharmacy2U£101£151£196£276
Boots-tier (Numan)£129£179£229£299
Well Pharmacy£94£154£210n/a
Simple Online Pharmacy£103£129£193£333
Zava£103£154£194£264
Juniper£149£164£214£299

A few things stand out from looking at fifty-plus UK pharmacies on this drug:

  • The starter dose (0.25 mg) ranges from about £80 to £150. The cheapest end is usually a first-month introductory price; the higher end is the standard rate. Some pharmacies price the first three lower doses identically (Asda, Click 2 Pharmacy, Curely) on the logic that they are dispensing the same packs at similar wholesale costs.
  • The 2.4 mg maintenance dose clusters around £190 to £230 across the mainstream pharmacies. Below £180 is unusual at standard retail; above £250 is a premium-service pharmacy (Goodbody Clinic at £290, Slimming Direct at £284).
  • The 7.2 mg dose is materially more expensive. It is dispensed less commonly and stock is tighter. £260 to £330 is the typical retail band, and several pharmacies do not stock it at all.
  • First-order discounts of £30 to £85 are widespread. That brings the effective month-one cost down meaningfully, but the price reverts to retail at refill. Plan your budget around the standard column, not the introductory column.

Boots, Lloyds, Asda, and the high street

Boots, Lloyds, and Asda all run private Wegovy services, with Asda routing through its own pharmacy chain and Lloyds operating LloydsDirect for online dispensing. Pricing through these high-street chains tends to sit in the middle of the market: not the cheapest, but not the most expensive either. Asda's published retail prices ran £92 (0.25 mg) to £252 (7.2 mg) in mid-2026. Lloyds ran £106 to £296 across the same range. Both require an online consultation with a prescriber before the first prescription is issued.

Boots took longer than the online-only competitors to roll out a Wegovy service nationally, partly because of supply constraints at launch in 2023. Their pricing today is broadly comparable to the upper end of the chain pharmacies. You pay slightly more for the in-person consultation route at a Boots store, less for the Boots Online Doctor digital route, and the trade-off is whether you want a face-to-face conversation with a prescriber or you are comfortable doing the whole thing through a screen.

Why Wegovy costs more than Ozempic in the UK

Both products are semaglutide. The molecule is identical. The pricing difference is structural, not pharmacological.

Ozempic is licensed in the UK for type 2 diabetes and is prescribed off-licence for weight loss only in narrow circumstances. The wholesale list price for Ozempic 1 mg is around £73 per month. Private off-licence prescriptions of Ozempic for weight loss are now restricted by MHRA guidance issued in 2023 that asked prescribers and pharmacies to prioritise diabetic patients during the global supply crunch.

Wegovy 2.4 mg uses a higher dose of semaglutide, comes in a different FlexTouch pen, is licensed specifically for chronic weight management, and is priced into a different commercial tier by Novo Nordisk. The list price of £175.80 per 2.4 mg pack reflects that positioning. Private pharmacies adding their consultation, dispensing, and delivery margin on top is what pushes the retail price into the £190 to £230 zone for the maintenance dose.

In short, Ozempic was priced for a diabetes market that the NHS reimburses heavily, Wegovy was priced for a private and limited-access NHS weight management market. Same molecule, different commercial product, different price.

Private Wegovy versus private Mounjaro in the UK

Mounjaro (tirzepatide) is the closer comparator for most UK patients pricing private weight loss treatment now, because both are widely available privately and both are weight-loss-licensed.

ItemWegovy 2.4 mgMounjaro 15 mg
Active ingredientSemaglutideTirzepatide
Receptor targetGLP-1 onlyGLP-1 and GIP
Typical private monthly cost (UK)£190 to £230£200 to £260
ManufacturerNovo NordiskEli Lilly
NHS pathwayTA875, specialist clinics, 2-year defaultTA1026, specialist clinics, phased rollout
Average weight loss in trials~15% at 68 weeks (STEP-1)~20% at 72 weeks (SURMOUNT-1)

Private Mounjaro typically runs £10 to £40 a month more than private Wegovy at equivalent maintenance doses, with a wider price spread because pharmacies discount Mounjaro more aggressively in 2026 than they discount Wegovy. The clinical case for paying more for Mounjaro rests on the SURMOUNT-1 weight loss numbers, which beat the STEP-1 Wegovy numbers head-to-head in indirect comparison. The clinical case for staying on Wegovy is a longer safety track record, including the SELECT trial cardiovascular outcomes data that Mounjaro does not yet have.

What a 12-month course actually costs

Annual private Wegovy cost depends almost entirely on how long you sit at the higher doses. A typical titration runs four weeks each at 0.25, 0.5, 1.0, and 1.7 mg, then maintenance at 2.4 mg. If you stay on 2.4 mg for the rest of the year:

  • 4 weeks at £100 = £100
  • 4 weeks at £120 = £120
  • 4 weeks at £140 = £140
  • 4 weeks at £180 = £180
  • 36 weeks at £200 (£200/month) = £1,800
  • Total year one: roughly £2,340 in medication

That is mid-range pricing at a mainstream online pharmacy. Premium services push the figure to £3,000 or more. Cheaper online pharmacies bring it down to around £2,000. On the NHS in England, the same year costs at most £114.50 with a prescription prepayment certificate, and nothing in Scotland, Wales, or Northern Ireland.

A second-year course at maintenance dose, no titration, runs around £2,400 at retail. Most people on private Wegovy report that the medication cost is the bulk of total spend; consultation fees of £20 to £50 every three to six months and occasional delivery charges add a modest overhead on top.

Getting genuine product: the MHRA, GPhC, and avoiding fakes

Every Wegovy pen sold legally in the UK ships through a pharmacy registered with the General Pharmaceutical Council (GPhC) and prescribed by a clinician registered with the General Medical Council, Nursing and Midwifery Council, or General Pharmaceutical Council (independent prescriber). The MHRA enforces this by removing illegal listings and prosecuting unlicensed sellers [4].

Three checks before you buy:

  1. GPhC pharmacy number. Every legitimate UK pharmacy displays its GPhC premises number on the website footer. Cross-check the number against the GPhC register at pharmacyregulation.org. If the pharmacy name on the register does not match the website, walk away.
  2. Prescriber consultation. A legitimate provider asks for medical history, BMI, current medications, and any contraindications before issuing a prescription. If the site lets you add Wegovy to a basket and check out like a t-shirt, it is operating illegally.
  3. Pen packaging. Genuine Wegovy ships in Novo Nordisk-branded cartons with batch numbers, an expiry date, and a Patient Information Leaflet in English. The pen itself is a blue FlexTouch device labelled with the strength. Anything sold in vials, anything in foreign-language-only packaging, anything labelled as "research only" or "reconstitute first" is not Wegovy.

Wegovy and Saxenda: what changed

Saxenda (liraglutide 3 mg) was the previous weight loss injectable from Novo Nordisk before Wegovy. UK private pricing for Saxenda ran £80 to £100 per pen, with most people on a daily injection going through one pen every six days. Annualised cost was roughly £4,000 to £5,000, materially higher than Wegovy at maintenance dose. Saxenda is now largely displaced by Wegovy and Mounjaro in private practice, and NHS prescribing was always limited to specialist clinics under earlier NICE guidance. If you are still on Saxenda, the cost case for switching to weekly Wegovy is straightforward; ask your prescriber.

Frequently asked Wegovy cost questions

How much does Wegovy cost on the NHS in 2026?
£9.90 per prescription item in England, free at the point of dispensing in Scotland, Wales, and Northern Ireland. A 12-month prescription prepayment certificate caps England's total at £114.50.
How much does Wegovy cost privately per month in the UK?
Roughly £130 to £300 per month depending on the dose and the pharmacy. Starter doses are at the lower end, the 2.4 mg maintenance dose clusters around £190 to £230, and the 7.2 mg high-dose pen runs £260 to £330.
What is the annual cost of private Wegovy in the UK?
A full year of private Wegovy including the 16 to 20 week titration plus 32 weeks of maintenance dose runs about £2,000 to £3,000 at mainstream online pharmacies, plus consultation and delivery fees.
How much does the Wegovy 1.7 mg dose cost?
The NICE-listed wholesale price is £124.53 per pack of four pens. Private retail runs roughly £140 to £200 across major UK pharmacies, with Asda at £172, Lloyds at £186, and Numan at £209 in mid-2026.
Who qualifies for Wegovy on the NHS?
Adults with BMI of at least 35, or BMI 30 to 34.9 with a weight-related condition like type 2 diabetes or hypertension, referred through a Tier 3 specialist weight management service. Thresholds drop by 2.5 kg/m² for several minority ethnic groups.
Is the NHS 2-year cap on Wegovy still in place?
The two-year course is the default under NICE TA875. NHS England has allowed integrated care boards to support continuation past two years where benefit is sustained, but most ICBs still apply the cap strictly. Continuation is not guaranteed.
Why does Wegovy cost more than Ozempic in the UK?
Both contain semaglutide, but Wegovy is licensed for weight management at a higher dose, priced by Novo Nordisk in a different commercial tier, and dispensed through private weight loss channels with consultation and delivery overhead.
How does private Mounjaro pricing compare to Wegovy?
Mounjaro maintenance dose (15 mg) runs about £200 to £260 per month privately, typically £10 to £40 more than equivalent Wegovy. Mounjaro has stronger trial weight loss data; Wegovy has the SELECT cardiovascular outcomes evidence.
Where can I get genuine Wegovy in the UK?
From a GPhC-registered pharmacy after consultation with a registered prescriber. Cross-check the pharmacy's GPhC premises number on pharmacyregulation.org. Avoid any seller that does not require a prescription or ships product in unbranded packaging.
Does private health insurance cover Wegovy in the UK?
Most UK private medical insurance policies exclude weight management drugs, so Wegovy is rarely covered. Check your policy wording directly. A small number of employer occupational health schemes are starting to include GLP-1 cover.
Can my GP prescribe Wegovy?
Not as a first prescription. NHS Wegovy must be initiated by a Tier 3 specialist weight management service. Some GPs can continue repeats after specialist handover, depending on local ICB policy.

What this page does not cover

This is the UK pricing reference. Whether Wegovy is right for you clinically, how to manage the side effect profile during titration, and how Wegovy compares to compounded semaglutide (which is not legal to dispense in the UK in the way it is in the US) have their own dedicated pages on this site. The price you pay is one factor; suitability and supervision are the others. Use the search to find the clinical and dosing articles, and use the table above to budget the financial side.

References

  1. NICE technology appraisal TA875, Semaglutide for managing overweight and obesity
  2. Wegovy (semaglutide) Summary of Product Characteristics, electronic Medicines Compendium
  3. NHS England, Specialist weight management services and obesity drugs
  4. MHRA, Buying medicines online safely
  5. BBC News reporting on Wegovy NHS rollout and supply